Correlation Between Akero Therapeutics and Cassava Sciences
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Cassava Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Cassava Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Cassava Sciences, you can compare the effects of market volatilities on Akero Therapeutics and Cassava Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Cassava Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Cassava Sciences.
Diversification Opportunities for Akero Therapeutics and Cassava Sciences
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Akero and Cassava is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Cassava Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cassava Sciences and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Cassava Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cassava Sciences has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Cassava Sciences go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Cassava Sciences
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.5 times more return on investment than Cassava Sciences. However, Akero Therapeutics is 1.99 times less risky than Cassava Sciences. It trades about 0.15 of its potential returns per unit of risk. Cassava Sciences is currently generating about 0.03 per unit of risk. If you would invest 2,933 in Akero Therapeutics on August 26, 2024 and sell it today you would earn a total of 340.00 from holding Akero Therapeutics or generate 11.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Cassava Sciences
Performance |
| Timeline |
| Akero Therapeutics |
| Cassava Sciences |
Akero Therapeutics and Cassava Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Cassava Sciences
The main advantage of trading using opposite Akero Therapeutics and Cassava Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Cassava Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cassava Sciences will offset losses from the drop in Cassava Sciences' long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| Cassava Sciences vs. Annovis Bio | Cassava Sciences vs. Axsome Therapeutics | Cassava Sciences vs. Reviva Pharmaceuticals Holdings | Cassava Sciences vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |